BRAND_ANALYSIS#ASTRAZENECAHEALTH & PHARMA#15 OF 26 IN HEALTH & PHARMAINTERESTING
AstraZeneca
· Public · Updated 09 Apr 2026 08:47 UTC
#281 of 1208 overall by tension · #15 of 26 in Health & Pharma
16Interesting
The Silent Giant
Analysis
AstraZeneca occupies the peculiar position of a pharma giant with genuine cultural traction (C=57), yet the 16-point gap to business performance (B=73) suggests the public respects the science more than the brand. A 4.78% stock bump indicates markets trust execution over narrative.
IN THE NEWS (100 articles this week)
Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression - Fierce Pharma